Acute intermittent porphyria?(AIP), also called?Swedish porphyria,?pyrroloporphyria,?intermittent acute porphyria) is a rare?autosomal?dominant?metabolic disorder?affecting the production of?heme?resulting from a deficiency of the?porphobilinogen deaminase. It is the most common of the acute porphyrias.
This report aims to provide a comprehensive presentation of the global market for Acute Intermittent Porphyria Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acute Intermittent Porphyria Drugs. This report contains market size and forecasts of Acute Intermittent Porphyria Drugs in global, including the following market information:
Global Acute Intermittent Porphyria Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Acute Intermittent Porphyria Drugs Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Acute Intermittent Porphyria Drugs companies in 2022 (%)
The global Acute Intermittent Porphyria Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
350mg Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Acute Intermittent Porphyria Drugs include Abbott. etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Acute Intermittent Porphyria Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Acute Intermittent Porphyria Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Acute Intermittent Porphyria Drugs Market Segment Percentages, by Type, 2022 (%)
350mg
313mg
Global Acute Intermittent Porphyria Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Acute Intermittent Porphyria Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Pharmacy
Global Acute Intermittent Porphyria Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Acute Intermittent Porphyria Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Acute Intermittent Porphyria Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Acute Intermittent Porphyria Drugs revenues share in global market, 2022 (%)
Key companies Acute Intermittent Porphyria Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Acute Intermittent Porphyria Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Outline of Major Chapters:
Chapter 1: Introduces the definition of Acute Intermittent Porphyria Drugs, market overview.
Chapter 2: Global Acute Intermittent Porphyria Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Acute Intermittent Porphyria Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Acute Intermittent Porphyria Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Acute Intermittent Porphyria Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Acute Intermittent Porphyria Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Acute Intermittent Porphyria Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Acute Intermittent Porphyria Drugs Overall Market Size
2.1 Global Acute Intermittent Porphyria Drugs Market Size: 2022 VS 2029
2.2 Global Acute Intermittent Porphyria Drugs Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Acute Intermittent Porphyria Drugs Sales: 2018-2029
3 Company Landscape
3.1 Top Acute Intermittent Porphyria Drugs Players in Global Market
3.2 Top Global Acute Intermittent Porphyria Drugs Companies Ranked by Revenue
3.3 Global Acute Intermittent Porphyria Drugs Revenue by Companies
3.4 Global Acute Intermittent Porphyria Drugs Sales by Companies
3.5 Global Acute Intermittent Porphyria Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Acute Intermittent Porphyria Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Acute Intermittent Porphyria Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Acute Intermittent Porphyria Drugs Players in Global Market
3.8.1 List of Global Tier 1 Acute Intermittent Porphyria Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Acute Intermittent Porphyria Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Acute Intermittent Porphyria Drugs Market Size Markets, 2022 & 2029
4.1.2 350mg
4.1.3 313mg
4.2 By Type - Global Acute Intermittent Porphyria Drugs Revenue & Forecasts
4.2.1 By Type - Global Acute Intermittent Porphyria Drugs Revenue, 2018-2023
4.2.2 By Type - Global Acute Intermittent Porphyria Drugs Revenue, 2024-2029
4.2.3 By Type - Global Acute Intermittent Porphyria Drugs Revenue Market Share, 2018-2029
4.3 By Type - Global Acute Intermittent Porphyria Drugs Sales & Forecasts
4.3.1 By Type - Global Acute Intermittent Porphyria Drugs Sales, 2018-2023
4.3.2 By Type - Global Acute Intermittent Porphyria Drugs Sales, 2024-2029
4.3.3 By Type - Global Acute Intermittent Porphyria Drugs Sales Market Share, 2018-2029
4.4 By Type - Global Acute Intermittent Porphyria Drugs Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Acute Intermittent Porphyria Drugs Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Pharmacy
5.2 By Application - Global Acute Intermittent Porphyria Drugs Revenue & Forecasts
5.2.1 By Application - Global Acute Intermittent Porphyria Drugs Revenue, 2018-2023
5.2.2 By Application - Global Acute Intermittent Porphyria Drugs Revenue, 2024-2029
5.2.3 By Application - Global Acute Intermittent Porphyria Drugs Revenue Market Share, 2018-2029
5.3 By Application - Global Acute Intermittent Porphyria Drugs Sales & Forecasts
5.3.1 By Application - Global Acute Intermittent Porphyria Drugs Sales, 2018-2023
5.3.2 By Application - Global Acute Intermittent Porphyria Drugs Sales, 2024-2029
5.3.3 By Application - Global Acute Intermittent Porphyria Drugs Sales Market Share, 2018-2029
5.4 By Application - Global Acute Intermittent Porphyria Drugs Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Acute Intermittent Porphyria Drugs Market Size, 2022 & 2029
6.2 By Region - Global Acute Intermittent Porphyria Drugs Revenue & Forecasts
6.2.1 By Region - Global Acute Intermittent Porphyria Drugs Revenue, 2018-2023
6.2.2 By Region - Global Acute Intermittent Porphyria Drugs Revenue, 2024-2029
6.2.3 By Region - Global Acute Intermittent Porphyria Drugs Revenue Market Share, 2018-2029
6.3 By Region - Global Acute Intermittent Porphyria Drugs Sales & Forecasts
6.3.1 By Region - Global Acute Intermittent Porphyria Drugs Sales, 2018-2023
6.3.2 By Region - Global Acute Intermittent Porphyria Drugs Sales, 2024-2029
6.3.3 By Region - Global Acute Intermittent Porphyria Drugs Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Acute Intermittent Porphyria Drugs Revenue, 2018-2029
6.4.2 By Country - North America Acute Intermittent Porphyria Drugs Sales, 2018-2029
6.4.3 US Acute Intermittent Porphyria Drugs Market Size, 2018-2029
6.4.4 Canada Acute Intermittent Porphyria Drugs Market Size, 2018-2029
6.4.5 Mexico Acute Intermittent Porphyria Drugs Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Acute Intermittent Porphyria Drugs Revenue, 2018-2029
6.5.2 By Country - Europe Acute Intermittent Porphyria Drugs Sales, 2018-2029
6.5.3 Germany Acute Intermittent Porphyria Drugs Market Size, 2018-2029
6.5.4 France Acute Intermittent Porphyria Drugs Market Size, 2018-2029
6.5.5 U.K. Acute Intermittent Porphyria Drugs Market Size, 2018-2029
6.5.6 Italy Acute Intermittent Porphyria Drugs Market Size, 2018-2029
6.5.7 Russia Acute Intermittent Porphyria Drugs Market Size, 2018-2029
6.5.8 Nordic Countries Acute Intermittent Porphyria Drugs Market Size, 2018-2029
6.5.9 Benelux Acute Intermittent Porphyria Drugs Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Acute Intermittent Porphyria Drugs Revenue, 2018-2029
6.6.2 By Region - Asia Acute Intermittent Porphyria Drugs Sales, 2018-2029
6.6.3 China Acute Intermittent Porphyria Drugs Market Size, 2018-2029
6.6.4 Japan Acute Intermittent Porphyria Drugs Market Size, 2018-2029
6.6.5 South Korea Acute Intermittent Porphyria Drugs Market Size, 2018-2029
6.6.6 Southeast Asia Acute Intermittent Porphyria Drugs Market Size, 2018-2029
6.6.7 India Acute Intermittent Porphyria Drugs Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Acute Intermittent Porphyria Drugs Revenue, 2018-2029
6.7.2 By Country - South America Acute Intermittent Porphyria Drugs Sales, 2018-2029
6.7.3 Brazil Acute Intermittent Porphyria Drugs Market Size, 2018-2029
6.7.4 Argentina Acute Intermittent Porphyria Drugs Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Acute Intermittent Porphyria Drugs Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Acute Intermittent Porphyria Drugs Sales, 2018-2029
6.8.3 Turkey Acute Intermittent Porphyria Drugs Market Size, 2018-2029
6.8.4 Israel Acute Intermittent Porphyria Drugs Market Size, 2018-2029
6.8.5 Saudi Arabia Acute Intermittent Porphyria Drugs Market Size, 2018-2029
6.8.6 UAE Acute Intermittent Porphyria Drugs Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Abbott
7.1.1 Abbott Company Summary
7.1.2 Abbott Business Overview
7.1.3 Abbott Acute Intermittent Porphyria Drugs Major Product Offerings
7.1.4 Abbott Acute Intermittent Porphyria Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Abbott Key News & Latest Developments
8 Global Acute Intermittent Porphyria Drugs Production Capacity, Analysis
8.1 Global Acute Intermittent Porphyria Drugs Production Capacity, 2018-2029
8.2 Acute Intermittent Porphyria Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Acute Intermittent Porphyria Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Acute Intermittent Porphyria Drugs Supply Chain Analysis
10.1 Acute Intermittent Porphyria Drugs Industry Value Chain
10.2 Acute Intermittent Porphyria Drugs Upstream Market
10.3 Acute Intermittent Porphyria Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Acute Intermittent Porphyria Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Acute Intermittent Porphyria Drugs in Global Market
Table 2. Top Acute Intermittent Porphyria Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Acute Intermittent Porphyria Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Acute Intermittent Porphyria Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Acute Intermittent Porphyria Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Acute Intermittent Porphyria Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Acute Intermittent Porphyria Drugs Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Acute Intermittent Porphyria Drugs Product Type
Table 9. List of Global Tier 1 Acute Intermittent Porphyria Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Acute Intermittent Porphyria Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Acute Intermittent Porphyria Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Acute Intermittent Porphyria Drugs Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Acute Intermittent Porphyria Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Acute Intermittent Porphyria Drugs Sales (K Units), 2024-2029
Table 16. By Application ? Global Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Acute Intermittent Porphyria Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Acute Intermittent Porphyria Drugs Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Acute Intermittent Porphyria Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Acute Intermittent Porphyria Drugs Sales (K Units), 2024-2029
Table 21. By Region ? Global Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Acute Intermittent Porphyria Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Acute Intermittent Porphyria Drugs Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Acute Intermittent Porphyria Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Acute Intermittent Porphyria Drugs Sales (K Units), 2024-2029
Table 26. By Country - North America Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Acute Intermittent Porphyria Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Acute Intermittent Porphyria Drugs Sales, (K Units), 2024-2029
Table 30. By Country - Europe Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Acute Intermittent Porphyria Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Acute Intermittent Porphyria Drugs Sales, (K Units), 2024-2029
Table 34. By Region - Asia Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Acute Intermittent Porphyria Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Acute Intermittent Porphyria Drugs Sales, (K Units), 2024-2029
Table 38. By Country - South America Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Acute Intermittent Porphyria Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Acute Intermittent Porphyria Drugs Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Acute Intermittent Porphyria Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Acute Intermittent Porphyria Drugs Sales, (K Units), 2024-2029
Table 46. Abbott Company Summary
Table 47. Abbott Acute Intermittent Porphyria Drugs Product Offerings
Table 48. Abbott Acute Intermittent Porphyria Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Abbott Key News & Latest Developments
Table 50. Acute Intermittent Porphyria Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 51. Global Acute Intermittent Porphyria Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 52. Global Acute Intermittent Porphyria Drugs Production by Region, 2018-2023 (K Units)
Table 53. Global Acute Intermittent Porphyria Drugs Production by Region, 2024-2029 (K Units)
Table 54. Acute Intermittent Porphyria Drugs Market Opportunities & Trends in Global Market
Table 55. Acute Intermittent Porphyria Drugs Market Drivers in Global Market
Table 56. Acute Intermittent Porphyria Drugs Market Restraints in Global Market
Table 57. Acute Intermittent Porphyria Drugs Raw Materials
Table 58. Acute Intermittent Porphyria Drugs Raw Materials Suppliers in Global Market
Table 59. Typical Acute Intermittent Porphyria Drugs Downstream
Table 60. Acute Intermittent Porphyria Drugs Downstream Clients in Global Market
Table 61. Acute Intermittent Porphyria Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Acute Intermittent Porphyria Drugs Segment by Type in 2022
Figure 2. Acute Intermittent Porphyria Drugs Segment by Application in 2022
Figure 3. Global Acute Intermittent Porphyria Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Acute Intermittent Porphyria Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Acute Intermittent Porphyria Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. Acute Intermittent Porphyria Drugs Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Acute Intermittent Porphyria Drugs Revenue in 2022
Figure 9. By Type - Global Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Acute Intermittent Porphyria Drugs Revenue Market Share, 2018-2029
Figure 11. By Type - Global Acute Intermittent Porphyria Drugs Sales Market Share, 2018-2029
Figure 12. By Type - Global Acute Intermittent Porphyria Drugs Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Acute Intermittent Porphyria Drugs Revenue Market Share, 2018-2029
Figure 15. By Application - Global Acute Intermittent Porphyria Drugs Sales Market Share, 2018-2029
Figure 16. By Application - Global Acute Intermittent Porphyria Drugs Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Acute Intermittent Porphyria Drugs Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Acute Intermittent Porphyria Drugs Revenue Market Share, 2018-2029
Figure 20. By Region - Global Acute Intermittent Porphyria Drugs Sales Market Share, 2018-2029
Figure 21. By Country - North America Acute Intermittent Porphyria Drugs Revenue Market Share, 2018-2029
Figure 22. By Country - North America Acute Intermittent Porphyria Drugs Sales Market Share, 2018-2029
Figure 23. US Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Acute Intermittent Porphyria Drugs Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Acute Intermittent Porphyria Drugs Sales Market Share, 2018-2029
Figure 28. Germany Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. France Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Acute Intermittent Porphyria Drugs Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Acute Intermittent Porphyria Drugs Sales Market Share, 2018-2029
Figure 37. China Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. India Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Acute Intermittent Porphyria Drugs Revenue Market Share, 2018-2029
Figure 43. By Country - South America Acute Intermittent Porphyria Drugs Sales Market Share, 2018-2029
Figure 44. Brazil Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Acute Intermittent Porphyria Drugs Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Acute Intermittent Porphyria Drugs Sales Market Share, 2018-2029
Figure 48. Turkey Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Acute Intermittent Porphyria Drugs Revenue, (US$, Mn), 2018-2029
Figure 52. Global Acute Intermittent Porphyria Drugs Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Acute Intermittent Porphyria Drugs by Region, 2022 VS 2029
Figure 54. Acute Intermittent Porphyria Drugs Industry Value Chain
Figure 55. Marketing Channels
